Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3 - Wikidata - wikimedia - TriplyDB

Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3

Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3

http://www.wikidata.org/entity/Q34073234

about

Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer Insulin-like growth factor system in cancer: novel targeted therapies EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I Genomic interaction profiles in breast cancer reveal altered chromatin architecture.Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells.Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells to EGFR-tyrosine kinase inhibitors.Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium.Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins Association of insulin and insulin-like growth factors with Barrett's oesophagus.Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro.The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis.IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment Molecular-targeted agents combination therapy for cancer: developments and potentials.Epidermal growth factor receptor: an important target in esophageal cancer.Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.Epidermal growth factor expression in esophageal adenocarcinoma: a clinically relevant target?IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.Risk factors for Barrett's esophagus.Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells.IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

P2860

Q24604176-FDEFDE03-3643-4451-9581-7DE88B9A9785 Q26801886-6545E80E-CC53-4C1D-928F-34474476D757 Q28081603-122FC175-3D9F-4A72-9040-A627F90D8F7C Q28275900-235ECD6F-4E97-43A5-AD99-728B7722633E Q31137734-B16A3D9E-0475-46A8-BAFC-83D2C246E529 Q33591112-794F8208-5303-4340-B961-1932997303C0 Q33685277-7045DA8D-606D-4B0E-A16C-DF8D1C3A8BF3 Q33705258-B9B96A6B-5229-42FC-8713-A65847770D3B Q33719968-8F637DD4-392E-4362-B93B-0F004DB44417 Q34356588-CC09C921-050A-4F80-BE40-528CB9B1D2CF Q35067488-1847E779-C7ED-4A83-B682-D4D36D7163B4 Q35987892-475C81B1-375C-461B-9A98-3A59A8CB3115 Q36062763-C5E2EEC9-549A-41FD-8E77-6F47C6823D37 Q36517741-B6C82DCC-5337-47C8-A3C8-7E04B1147F2E Q36561601-29AB7805-718E-4035-83C8-FA35FFBC027E Q36726112-4C1335A1-DA55-4B5D-A979-4347A2DDF1BC Q36893433-ABF12480-4436-489E-9A6A-218B609FE75B Q37077239-AD0D75C8-DD49-4871-AC77-1AA44D680B98 Q37188567-1C9CA47C-BFC9-4583-BFCC-5CDFD4C1286B Q37398529-D2D41100-3468-47CC-A2DD-4BAB638C1DFD Q37428196-D60D387C-E6E3-4F2F-BC7E-6F270F029E54 Q37508817-A495F407-EE0A-456E-972A-7906FB63C8AC Q37516299-989964A1-EE1F-474B-92A7-5A69EFB23AB1 Q38104670-0E809EF2-2B98-43DB-8170-CF36634FD26E Q38121640-DC9D9C5B-9C1E-48E0-852E-3C605F64581F Q38586626-09BF4145-40FF-405C-8714-669AF22E65E9 Q38905550-54150086-998A-4BD7-A9EC-43BE2D08349B Q39096931-4A2AB35D-423E-45BC-800F-224CD8A7F8F2 Q39385922-0B2BD6D9-6180-48B8-B5B3-F9A627A6FB47 Q39441997-3AD6560B-50BC-45B0-8182-21B18A833C5B Q39654146-8191AD6B-CD92-4B4B-9925-36B6A9BFDAC6 Q40238825-B672ADCA-EF52-444A-903F-9EFE9D36B660 Q40879184-37CC9BF8-AC1F-4FB7-BF07-8A1BF6DD527E Q41376475-B708DE6E-793C-4023-91DB-38FA0AE2A3DE Q42119902-119C531A-2205-43E4-B4D9-8CF5EF932FCD Q50997794-58F7F5D3-2AB1-42C4-8F63-E22193D2040D Q52854999-E1CE8A13-A754-49F3-984F-3492F1F4E1F8 Q55230047-B21E5E28-25D4-4287-83CA-001AD1194A1B

P2860

Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3

http://www.wikidata.org/entity/Q34073234

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Epidermal growth factor recept ...... rowth factor-binding protein 3

@ast

Epidermal growth factor recept ...... rowth factor-binding protein 3

@en

Epidermal growth factor recept ...... rowth factor-binding protein 3

@nl

type

label

Epidermal growth factor recept ...... rowth factor-binding protein 3

@ast

Epidermal growth factor recept ...... rowth factor-binding protein 3

@en

Epidermal growth factor recept ...... rowth factor-binding protein 3

@nl

prefLabel

Epidermal growth factor recept ...... rowth factor-binding protein 3

@ast

Epidermal growth factor recept ...... rowth factor-binding protein 3

@en

Epidermal growth factor recept ...... rowth factor-binding protein 3

@nl

P1433

Q34073234-253AD190-E222-45B1-9028-F96C51469A57

P1476

Q34073234-5573BAFE-5537-4F1D-9D52-633CFE7BA681

P2093

Q34073234-43E4DC47-C2D2-481C-BBF7-815E7FA1376D

Q34073234-6CD1F54F-EAAD-4D58-852B-696FF093F117

Q34073234-6D97250D-4FEA-46FC-B1C7-1F41DED094F7

Q34073234-7543606B-6000-42B4-8C63-E12C034817DD

Q34073234-9B9610D5-63D8-4961-9BD4-DD2B5E35552E

Q34073234-A16A2DBC-0813-4222-97ED-4406EF1376D1

Q34073234-D4DFB88A-A8BB-4227-9840-ADA2DAB7E7C6

Q34073234-D7A632EB-EBAE-4EED-9C49-0F407E9D7C4A

Q34073234-FEED8FF4-D176-4C76-A100-6394C50B8F19

P2860

Q34073234-01F20AAD-EA5B-45D9-92CC-298314712260

Q34073234-05D4A499-E0CA-4C4A-BBCE-BFEE9B8AF3EA

Q34073234-0A6B6099-93D2-4283-A6A3-C82AB9DBA004

Q34073234-0B1D0294-2D9A-4F8F-A91C-257F0E01D297

Q34073234-13C072AD-9006-42E3-8C67-5F817AE86F1B

Q34073234-16DBAEC5-0C0F-4743-9DCF-2B2501EF6AE3

Q34073234-1949CC5D-D4E8-4D2F-B793-FD1B323E6DF2

Q34073234-1AA2C151-EBC4-44AF-82EB-2D06FAA2AF33

Q34073234-1B75A11A-8EA0-4253-A666-585102BEE5E5

Q34073234-240A18A8-0765-478A-86BF-2CD81FEDF56F

P304

Q34073234-1EA623B5-C255-46AE-B418-FF5FE8362AB1

P31

Q34073234-DEE6EE38-B0B6-4884-990F-065CE3593E4F

P356

Q34073234-CA170850-C07E-48C7-989D-FDE532B74701

P407

Q34073234-166386D8-CADF-4CD6-815C-2BCC7308B81A

P433

Q34073234-3A5B8F70-8EF8-42F7-A677-6F9B4DC7D5AC

P478

Q34073234-9C183E34-DB10-41E1-BB2F-AA3EFC75968F

P50

Q34073234-04164E50-ECAE-46CB-97A3-D647EFBF18CB

P577

Q34073234-C23025E8-0E50-49D8-A8FD-237D28ECED66

P698

Q34073234-030BA779-B1D0-437B-8F6A-7DA7817D4FF4

P921

Q34073234-8EC47DA4-6057-4600-BB11-279E20DF2146

P932

Q34073234-3DAB7324-C3C2-41E7-8287-0509207A5EB1

P356

0008-5472.CAN-04-0715

P1433

Cancer Research

P1476

Epidermal growth factor recept ...... rowth factor-binding protein 3

@en

P2093

Adda Grimberg

http://www.w3.org/2001/XMLSchema#string

Andres J Klein-Szanto

http://www.w3.org/2001/XMLSchema#string

Claudia D Andl

http://www.w3.org/2001/XMLSchema#string

Hideki Harada

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nakagawa

http://www.w3.org/2001/XMLSchema#string

Kelly L Dempsey

http://www.w3.org/2001/XMLSchema#string

Kenji Oyama

http://www.w3.org/2001/XMLSchema#string

Munenori Takaoka

http://www.w3.org/2001/XMLSchema#string

Yoshio Naomoto

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

The insulin-like growth factor-binding protein (IGFBP) superfamily

Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma

Cellular actions of the insulin-like growth factor binding proteins

Induction of the growth inhibitor IGF-binding protein 3 by p53

Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures

Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

Subtractive hybridization of mRNA from early passage and senescent endothelial cells.

P304

7711-7723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-0715

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Wafik S. El-Deiry

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15520175

http://www.w3.org/2001/XMLSchema#string

P921

P932

4140096

http://www.w3.org/2001/XMLSchema#string